Concerns raised about the integrity of public health institutions and the vaccine industry due to mismanagement and corruption.
-
Technology limitations and mismanagement in targeting high-risk groups led to increased risks and exposure. • 0:20
-
People affected by the technology will continue to speak out, potentially leading to the downfall of the platform and the vaccine enterprise. • 0:57
-
Public faith in public health institutions like the CDC and FDA has been compromised, with accusations of corruption. • 1:30
-
Historically trusted regulatory bodies like the FDA are now being viewed as unreliable and corrupt, impacting public perception in Europe. • 1:55
Impact of rushed vaccine operation on US biopharmaceutical industry and global reputation.
-
US competitive position in biopharmaceuticals damaged, leading to import dependence on India and China. • 2:57
-
Reputation of FDA globally tarnished due to emergency use authorization of unsafe products. • 3:53
-
Initial overestimation of virus lethality by government officials, highlighting misinformation. • 4:14
-
Trump’s early correct assessment of virus mortality rate contradicted initial projections. • 4:41
Ethical breaches and lack of predictability in vaccine development processes raise concerns.
-
Initial beliefs of a highly lethal virus leading to extreme measures were based on false propaganda. • 4:58
-
International norms of ethics and product development have been compromised in the rush for vaccines. • 5:24
-
Colleagues in the industry are perplexed by the current state of vaccine development and regulatory affairs. • 5:32
-
Regulatory processes in the US have become unpredictable and less structured, causing confusion among developers. • 6:01
-
Integrity of the entire system is now at risk, with uncertainty on standards and potential corruption. • 6:44